MAIA Biotechnology, Inc.

Biotechnology • Healthcare • Chicago, IL, United States • MAIA (ASE)

MAIA Biotechnology, Inc., together with its subsidiaries, immuno-oncology company, focuses on the development and commercialization of drugs with novel mechanisms of action that are intended to improve and extend the lives of people with cancer. Its lead program is THIO, a potential cancer telomere targeting agent in clinical development for the treatment of NSCLC patients with telomerase-positive cancer cells. The company was incorporated in 2018 and is headquartered in Chicago, Illinois.

312 416 8592 444 West Lake Street, Chicago, IL 60606, United States

Stock Performance (90 Days)

Data through Dec 26, 2025

Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

MAIA Biotechnology Announces $1.51 Million Private Placement - Yahoo Finance

Yahoo Finance • Dec 16

MAIA Biotechnology announces $2.25M private placement deal - MSN

MSN • Dec 16

Director Makes Bold Move with Major Stock Purchase in MAIA Biotechnology! - TipRanks

TipRanks • Dec 9

MAIA Biotechnology (NYSE American: MAIA) begins Phase 3 NSCLC study of telomere-targeting ateganosine - Stock Titan

Stock Titan • Dec 11

Stan Smith buys MAIA Biotechnology shares worth $69,999 - Investing.com

Investing.com • Dec 23

Other Biotechnology Companies

Vertex Pharmaceuticals Inc. / MA

$118.68B market cap

Regeneron Pharmaceuticals, Inc.

$82.72B market cap

Alnylam Pharmaceuticals, Inc.

Frequently Asked Questions

Has MAIA Biotechnology, Inc. had layoffs?

No layoff events have been recorded for MAIA Biotechnology, Inc. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.

How many employees does MAIA Biotechnology, Inc. have?

MAIA Biotechnology, Inc. has approximately 13 employees.

What industry is MAIA Biotechnology, Inc. in?

MAIA Biotechnology, Inc. operates in the Biotechnology industry, within the Healthcare sector.

Is MAIA Biotechnology, Inc. a publicly traded company?

Yes, MAIA Biotechnology, Inc. is publicly traded under the ticker symbol MAIA on the ASE. The company has a market capitalization of approximately $0.06 billion.

Where is MAIA Biotechnology, Inc. headquartered?

MAIA Biotechnology, Inc. is headquartered in Chicago, IL, United States at 444 West Lake Street, Chicago, IL 60606, United States.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.